Anikó Magyariné Berkó

Anikó Magyariné Berkó

Auto-generated profile, based on publicly available information

Anikó Magyariné Berkó

Department of Physiology, Anatomy and Neuroscience, Faculty of Science and Informatics, University of Szeged, 6726 Szeged, Hungary

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2019 in Molecules
Verified
Journal Article
Open access
PDF file
Gábor J. SzebeniGábor J. Szebeni
Gábor J. Szebeni
LNLajos I. Nagy
Lajos I. Nagy
ABAnikó Berkó
Anikó Berkó
AHAlexandra Hoffmann
Alexandra Hoffmann
LFLiliána Z. Fehér
Liliána Z. Fehér
Laszlo PuskasLaszlo Puskas
Laszlo Puskas
The incidence of inflammatory bowel disease (IBD) increases gradually in Western countries with high need for novel therapeutic interventions. Mannich curcuminoids, C142 or C150 synthetized in our laboratory, have been tested for anti-inflammatory activity in a rat model of TNBS (2,4,6-trinitrobenzenesulphonic acid) induced colitis. Treatment with C142 or C150 reduced leukocyte infiltration to the submucosa and muscular propria of the inflamed gut. C142 or C150 rescued the loss of body weight and C150 decreased the weight of standard colon preparations proportional with 20% less tissue oedema. Both C142 and C150 curcumin analogues caused 25% decrease in the severity of colonic inflammation and haemorrhagic lesion size. Colonic MPO (myeloperoxidase) enzyme activity as an indicator of intense neutrophil infiltration was 50% decreased either by C142 or C150 Mannich curcuminoids. Lipopolysaccharide (LPS) co-treatment with Mannich curcuminoids inhibited NF-κB (nuclear factor kappa B) activity on a concentration-dependent manner in an NF-κB-driven luciferase expressing reporter cell line. Co-treatment with LPS and curcuminoids, C142 or C150, resulted in NF-κB inhibition with 3.57 μM or 1.6 μM half maximal effective concentration (EC50) values, respectively. C150 exerted a profound inhibition of the expression of inflammatory cytokines, tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and interleukin-4 (IL-4) in human PBMCs (peripheral blood mononuclear cells) upon LPS stimulus. Mannich curcuminoids reported herein possess a powerful anti-inflammatory activity.

27 August 2016 in Brain Structure and Function
Verified
Journal Article
Closed access
PDF file
JHJudit Herédi
Judit Herédi
ABAnikó Magyariné Berkó
Anikó Magyariné Berkó
FJFerenc Jankovics
Ferenc Jankovics
TITokuko Iwamori
Tokuko Iwamori
NINaoki Iwamori
Naoki Iwamori
LGLevente Gellért
Levente Gellért

1 February 2021 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
PDF file
DBDenise Börzsei
Denise Börzsei
DPDániel Priksz
Dániel Priksz
RSRenáta Szabó
Renáta Szabó
MBMariann Bombicz
Mariann Bombicz
ZKZoltán Karácsonyi
Zoltán Karácsonyi
APAnikó Pósa
Anikó Pósa
Voluntary exercise has proved to be an effective therapeutic tool to improve cardiac function in aged rats with clearly visible sex differences. Long-term exercise is associated with decreased Ogn and Comt expression and enhanced presence of Pcp4 and Esm1 genes. Sex-dependent changes were also observed in the expression of the cardiovascular key proteins. Fundamental alterations in gene and protein expression may contribute to the improvement of cardiac performance.

11 February 2003 in Surface Science
Verified
Journal Article
Closed access
ABA. Berkó
A. Berkó
JSJ. Szökő
J. Szökő
FSF. Solymosi
F. Solymosi

7 August 2019 in Antioxidants
Verified
Journal Article
Open access
PDF file
Renáta SzabóRenáta Szabó
Renáta Szabó
Denise BörzseiDenise Börzsei
Denise Börzsei
KKKrisztina Kupai
Krisztina Kupai
AHAlexandra Hoffmann
Alexandra Hoffmann
Rudolf GesztelyiRudolf Gesztelyi
Rudolf Gesztelyi
APAnikó Pósa
Anikó Pósa
A low testosterone level contributes to the development of oxidative damages; however, the cardiovascular effects of exogenous hormone therapy are not well elucidated. The aim of our work is to study the association of the testosterone level, antioxidant/oxidant system, and anti-inflammatory status related to the heme oxygenase (HO) system. To determine the effects of testosterone, 10-week-old, and 24-month-old sham-operated and castrated male Wistar rats were used. One part of the castrated animals was daily treated with 2.5 mg/kg cyproterone acetate, while the hormone replacement therapy was performed via an i.m. injection of a dose of 8.0 mg testosterone undecanoate/kg/once a week. The plasma testosterone level, the activity of HO and myeloperoxidase (MPO) enzymes; the concentrations of the HO-1, tumor necrosis alpha (TNF-α), and cyclic guanosine monophosphate (cGMP), as well as the total level of glutathione (GSH + GSSG) were determined from the cardiac left ventricle. In accordance with the testosterone values, the aging process and castration resulted in a decrease in antioxidant HO activity, HO-1 and cGMP concentrations and in the level of GSH + GSSG, whereas the inflammatory TNF-α and MPO activity significantly increased. Testosterone therapy was able to restore the physiological values. Our results clearly show that testosterone replacement therapy increases the antioxidant status and mitigates the inflammatory parameters via the modulation of the HO system.

1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
Renáta SzabóRenáta Szabó
Renáta Szabó
AHAlexandra Hoffmann
Alexandra Hoffmann
Denise BörzseiDenise Börzsei
Denise Börzsei
KKKrisztina Kupai
Krisztina Kupai
MVMédea Hegyköziné Dr Veszelka
Médea Hegyköziné Dr Veszelka
CVCsaba Varga
Csaba Varga
Advanced age is an independent risk factor for cardiovascular diseases, which might be further exacerbated by estrogen deficiency. Hormone replacement therapy (HRT) decreases cardiovascular risks and events in postmenopausal women; however, its effects are not fully elucidated in older individuals. Thus, the aim of our study is to examine the impact of HRT on oxidant/antioxidant homeostasis and cardiac remodeling. In our experiment, control (fertile) and aging (~20‐month‐old) female Wistar rats were used. Aging rats were further divided into estrogen‐ (E2, 0.1 mg/kg/day per os) or raloxifene‐ (RAL, 1.0 mg/kg/day per os) treated subgroups. After 2 weeks of treatment, cardiac heme oxygenase (HO) activity, total glutathione (GSH) content, matrix metalloproteinase‐2 (MMP‐2) activity, and the concentrations of collagen type I and tissue inhibitor of metalloproteinase (TIMP‐2), as well as the infarct size, were determined. The aging process significantly decreased the antioxidant HO activity and GSH content, altered the MMP‐2/TIMP‐2 signaling, and resulted in an excessive collagen accumulation, which culminated in cardiovascular injury. However, 2 weeks of either E2 or RAL treatment enhanced the antioxidant defense mechanisms and attenuated cardiac remodeling related to aging. Our findings clearly show that 2‐week‐long HRT is a potential intervention to bias successful cardiovascular aging via reducing oxidative damage and cardiovascular dysfunction.